Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Resverlogix's apabetalone shows favorable PK profile in severe renal impairment

Nov. 18, 2016

Sanford-Burnham Medical Research Institute patents APJ agonists

Nov. 18, 2016

Reata Pharmaceuticals announces plans to study bardoxolone methyl in new indication

Nov. 15, 2016

ChemoCentryx's CCX-168 leads to improvements in patient with C3 glomerulopathy

Oct. 28, 2016

FDA committee votes in favor of approving SER-120 for nocturia

Oct. 24, 2016

FDA accepts NDA resubmission for sodium zirconium cyclosilicate

Oct. 18, 2016

Omeros reports phase II data for OMS-721, pursuing FDA breakthrough therapy designation

Oct. 18, 2016

Phase II results lead NeuroVive to discontinue development of CicloMulsion for acute kidney injury

Oct. 13, 2016

Takeda Pharmaceutical presents EIT6 inhibitors

Oct. 13, 2016

Xenetic Biosciences reports positive data from phase II trial of erepoxen

Oct. 11, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...